Sign Up to like & get
recommendations!
0
Published in 2024 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.16362
Abstract: Evidence on the optimal targets of vancomycin for treating other Gram‐positive infections apart from methicillin‐resistant Staphylococcus aureus (MRSA) is lacking. This review aims to identify the recommended vancomycin therapeutic level for favourable clinical outcomes among…
read more here.
Keywords:
vancomycin sensitive;
review;
sensitive enterococcal;
enterococcal infections ... See more keywords